“Mean Girls” star Rachel McAdams may be walking away from Hollywood once and for all after putting her longtime Los Angeles home on the market for just a touch under $4 million—having ...

IVINS, Utah — Hae Ran Ryu regained control of the Black Desert Championship by holing out for eagle on the 11th hole, sending her to a 4-under 68 to maintain her two-shot lead in the LPGA Tour ...

IVINS, Utah (AP) — Hae Ran Ryu regained control of the Black Desert Championship by holing out for eagle on the 11th hole, sending her to a 4-under 68 to maintain her two-shot lead in the LPGA ...

Horror Shows Pedro Pascal recalls "shock and heartbreak" making pivotal The Last of Us season 2 scene: "I've never experienced anything like I did that day" Drama Shows The Last of Us season 2 ...

I’m friends with a girl, “Hannah,” who goes to my university. Hannah came from a pretty repressive household and is still a virgin, even though she’s 19. The other day, she made a request ...

Khloé Kardashian’s sculpted abs were front and center as the Good American co-founder enjoyed a getaway with her kids. Kardashian, 40, rocked a cherry-print string bikini top, white tennis ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2-mutant non-small cell lung cancer (NSCLC) in a multicohort phase Ia/Ib ...

Nearly all participants achieved disease control. Zongertinib conferred benefit in certain patients with previously treated HER2-mutant advanced non-small cell lung cancer in a phase 1 trial ...

Christina Applegate is opening up while in the throes of the early stages of grief. After JoAnna Garcia Swisher, the guest for the April 29 episode of Applegate's podcast "MeSsy," discussed the ...

It’s a “true precision oncology agent that was beautifully designed,” Canamasas mused, meant to inhibit only HER2 and not target EGFR, another more common NSCLC mutation. HER2 mutations are ...

Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...